Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
Holding AU:PTX?
Track your performance easily

Prescient Therapeutics Limited (PTX) Cash flow

9 Followers

Prescient Therapeutics Limited Cash Flow

AU:PTX's free cash flow for Q4 2022 was AU$―. For the 2022 fiscal year, AU:PTX's free cash flow was decreased by AU$-344.75K and operating cash flow was AU$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Operating Cash Flow
------
Investing Cash Flow
-AU$ -4.43KAU$ -2.31K--AU$ -1.52K
Financing Cash Flow
-AU$ 428.29KAU$ 12.75M-AU$ 8.37MAU$ -635.00
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-AU$ 12.26MAU$ 16.10MAU$ 7.36MAU$ 9.64MAU$ 5.49M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
----AU$ 3.30KAU$ 2.20K
Issuance Of Capital Stock
-AU$ 594.12KAU$ 13.58M-AU$ 9.12MAU$ 38.63K
Issuance Of Debt
------
Repayment Of Debt
-AU$ -165.83KAU$ 8.95K-AU$ -56.05KAU$ -37.42K
Free Cash Flow
-AU$ -4.32MAU$ -3.97MAU$ -2.32MAU$ -4.20MAU$ -2.15M
Domestic Sales
------
Foreign Sales
------
Currency in AUD

Prescient Therapeutics Limited Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis